ArticleFrontiers in oncology2022

Encouraging efficacy of a comprehensive therapy consisting of sintilimab, bevacizumab biosimilar IBI305, hypo-fractionated intensity-modulated radiotherapy, and oxaliplatin for a maxillary metastasis from hepatocellular carcinoma: A case report and literature review.

Xuexia Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.